| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,909 | 33,304 | 33,054 | 32,252 | | Cost of Revenue | 8,412 | 8,575 | 8,580 | 9,254 | | | Gross Profit |
-
| 24,729 | 24,474 | 22,998 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,811 | 15,675 | 14,624 | 15,797 | | Non Recurring |
-
|
-
|
-
| (13,962) | | Others | 7,141 | 6,428 | 2,164 | 16,734 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,626 | 7,686 | 4,429 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,545 | 2,626 | 7,686 | 4,429 | | Interest Expense | 3,467 | 3,501 | 3,510 | 3,825 | | Income Before Tax | (1,922) | (875) | 4,176 | 604 | | Income Tax Expense | (1,748) | (74) | 871 | (1,400) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (174) | (801) | 3,305 | 2,004 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (174) | (801) | 3,305 | 2,004 | | Preferred Stock And Other Adjustments | (462) | (462) | (414) |
-
| | | Net Income Applicable To Common Shares | ($636) | ($1,263) | $2,891 | $2,004 |
|
0.51% Nasdaq 
Income Statement
